Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
Sponsor: Shanghai Zhongshan Hospital
Summary
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Androgenetic Alopecia (AGA) in female adults. The main question it aims to answer is: • Does DHA increase terminal hair follicles in the vertex area. Researchers will compare oral DHA plus topical minoxidil to topical minoxidil alone in female patients with AGA to see if DHA works to alleviate AGA. Participants will: * Receive oral DHA every day plus topical minoxidil or use topical minoxidil alone for 6 months. * Visit the clinic once every month for checkups and tests.
Official title: A Pilot Study to Evaluate the Therapeutic Effect of Dihydroartemisinin on Female Androgenetic Alopecia
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-06
Completion Date
2026-12
Last Updated
2025-06-10
Healthy Volunteers
No
Conditions
Interventions
Oral DHA + Topical minoxidil 5%
DHA 20mg tid po plus daily topical minoxidil 5% for 180 days
Topical Minoxidil 5%
Topical minoxidil 5% daily for 180 days
Locations (1)
Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China